Literature DB >> 28808893

Epigenetics and Bone Remodeling.

Ali Husain1, Matlock A Jeffries2,3.   

Abstract

PURPOSE OF REVIEW: Bone remodeling is a diverse field of study with many direct clinical applications; past studies have implicated epigenetic alterations as key factors of both normal bone tissue development and function and diseases of pathologic bone remodeling. The purpose of this article is to review the most important recent advances that link epigenetic changes to the bone remodeling field. RECENT
FINDINGS: Epigenetics describes three major phenomena: DNA modification via methylation, histone side chain modifications, and short non-coding RNA sequences which work in concert to regulate gene transcription in a heritable fashion. Recent findings include the role of DNA methylation changes of Wnt, RANK/RANKL, and other key signaling pathways, epigenetic regulation of osteoblast and osteoclast differentiation, and others. Although much work has been done, much is still unknown. Future epigenome-wide studies should focus on extending the tissue coverage, integrating multiple epigenetic analyses with transcriptome data, and working to uncover epigenetic changes linked with early events in aberrant bone remodeling.

Entities:  

Keywords:  Bone remodeling; DNA methylation; Epigenetics; Histone modification; Review; miRNA

Mesh:

Substances:

Year:  2017        PMID: 28808893      PMCID: PMC5710824          DOI: 10.1007/s11914-017-0391-y

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  92 in total

1.  DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.

Authors:  Jesús Delgado-Calle; Carolina Sañudo; Alfonso Bolado; Agustín F Fernández; Jana Arozamena; María A Pascual-Carra; José C Rodriguez-Rey; Mario F Fraga; Lynda Bonewald; José A Riancho
Journal:  J Bone Miner Res       Date:  2012-04       Impact factor: 6.741

Review 2.  Perspectives on RUNX genes: an update.

Authors:  M Michael Cohen
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

3.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  RANKL induces NFATc1 acetylation and stability via histone acetyltransferases during osteoclast differentiation.

Authors:  Jung Ha Kim; Kabsun Kim; Bang Ung Youn; Hye Mi Jin; Ji-Young Kim; Jang Bae Moon; Aeran Ko; Sang-Beom Seo; Kwang-Youl Lee; Nacksung Kim
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

5.  Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures.

Authors:  Claudine Seeliger; Katrin Karpinski; Alexander T Haug; Helen Vester; Andreas Schmitt; Jan S Bauer; Martijn van Griensven
Journal:  J Bone Miner Res       Date:  2014-08       Impact factor: 6.741

6.  Decreased DNA methylation in the promoter region of the WNT5A and GDNF genes may promote the osteogenicity of mesenchymal stem cells from patients with ossified spinal ligaments.

Authors:  Noriyuki Chiba; Ken-Ichi Furukawa; Shohei Takayama; Toru Asari; Shunfu Chin; Yoshifumi Harada; Gentaro Kumagai; Kanichiro Wada; Toshihiro Tanaka; Atsushi Ono; Shigeru Motomura; Manabu Murakami; Yasuyuki Ishibashi
Journal:  J Pharmacol Sci       Date:  2015-04-01       Impact factor: 3.337

7.  Histone deacetylase 3 interacts with runx2 to repress the osteocalcin promoter and regulate osteoblast differentiation.

Authors:  Tania M Schroeder; Rachel A Kahler; Xiaodong Li; Jennifer J Westendorf
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

Review 8.  Functional interactions among microRNAs and long noncoding RNAs.

Authors:  Je-Hyun Yoon; Kotb Abdelmohsen; Myriam Gorospe
Journal:  Semin Cell Dev Biol       Date:  2014-06-02       Impact factor: 7.727

9.  A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population.

Authors:  Karen Staehling-Hampton; Sean Proll; Bryan W Paeper; Lei Zhao; Patrick Charmley; Analisa Brown; Jessica C Gardner; David Galas; Randall C Schatzman; Peter Beighton; Socrates Papapoulos; Herman Hamersma; Mary E Brunkow
Journal:  Am J Med Genet       Date:  2002-06-15

10.  MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation.

Authors:  Jian Huang; Lan Zhao; Lianping Xing; Di Chen
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

View more
  23 in total

Review 1.  Epigenetics of Skeletal Diseases.

Authors:  Alvaro Del Real; Leyre Riancho-Zarrabeitia; Laura López-Delgado; José A Riancho
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

Review 2.  Epigenetic regulation of bone remodeling by natural compounds.

Authors:  Nishikant Raut; Sheila M Wicks; Tempitope O Lawal; Gail B Mahady
Journal:  Pharmacol Res       Date:  2019-07-14       Impact factor: 7.658

Review 3.  Regulation of osteoclast-mediated bone resorption by microRNA.

Authors:  Ling Ji; Xinyi Li; Shushu He; Song Chen
Journal:  Cell Mol Life Sci       Date:  2022-05-10       Impact factor: 9.261

4.  LncRNA BC083743 Silencing Exacerbated Osteoporosis by Regulating the miR-103-3p/SATB2 Axis to Inhibit Osteogenic Differentiation.

Authors:  Feng Lu; Ling Tang
Journal:  Comput Intell Neurosci       Date:  2022-06-20

Review 5.  Sexual Dimorphism and the Origins of Human Spinal Health.

Authors:  Vicente Gilsanz; Tishya A L Wren; Skorn Ponrartana; Stefano Mora; Clifford J Rosen
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

6.  Histone methylation regulator PTIP is required to maintain normal and leukemic bone marrow niches.

Authors:  Prosun Das; Kylee J Veazey; Hieu T Van; Saakshi Kaushik; Kevin Lin; Yue Lu; Masaru Ishii; Junichi Kikuta; Kai Ge; Andre Nussenzweig; Margarida A Santos
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-08       Impact factor: 11.205

7.  Prioritization of Osteoporosis-Associated Genome-wide Association Study (GWAS) Single-Nucleotide Polymorphisms (SNPs) Using Epigenomics and Transcriptomics.

Authors:  Xiao Zhang; Hong-Wen Deng; Hui Shen; Melanie Ehrlich
Journal:  JBMR Plus       Date:  2021-03-19

8.  The KDM4B-CCAR1-MED1 axis is a critical regulator of osteoclast differentiation and bone homeostasis.

Authors:  Sun-Ju Yi; You-Jee Jang; Hye-Jung Kim; Kyubin Lee; Hyerim Lee; Yeojin Kim; Junil Kim; Seon Young Hwang; Jin Sook Song; Hitoshi Okada; Jae-Il Park; Kyuho Kang; Kyunghwan Kim
Journal:  Bone Res       Date:  2021-05-25       Impact factor: 13.567

9.  Endocrine-disrupting chemicals, epigenetics, and skeletal system dysfunction: exploration of links using bisphenol A as a model system.

Authors:  Frances Xin; Lauren M Smith; Martha Susiarjo; Marisa S Bartolomei; Karl J Jepsen
Journal:  Environ Epigenet       Date:  2018-04-26

10.  Radix Paeoniae Rubra stimulates osteoclast differentiation by activation of the NF-κB and mitogen-activated protein kinase pathways.

Authors:  Huey-En Tzeng; Chun-Hao Tsai; Tin-Yun Ho; Chin-Tung Hsieh; Shen-Chieh Chou; Yi-Ju Lee; Gregory J Tsay; Po-Hao Huang; Yi-Ying Wu
Journal:  BMC Complement Altern Med       Date:  2018-04-23       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.